About: Plasma-derived medicinal products

Health 14-06-2021

MEP: Clear EU definition of plasma would pave way for better awareness

Communication about the importance of plasma donations can be improved by focusing on a clear definition in the EU legislation, ensuring that more awareness is raised about the role it plays in producing life-saving medical products, a centre-right EU lawmaker told EURACTIV.
Health 07-05-2021

Commission: EU’s new blood directive to address dependency on US plasma

The ongoing revision of the European legislation on blood, tissues, and cells offers an opportunity to tackle the highly problematic dependency on plasma collected in the US for manufacturing plasma-derived medicinal products (PDMPs), according to an EU health official.
Health 01-04-2021

COVID-19 plasma therapy comes handy either way, EU Commission says

Even though the efficiency of plasma therapies against COVID-19 are not yet demonstrated, increasing Europe's blood collection capacity will contribute to address chronic shortages, the European Commission has said.
Health 17-03-2021

COVID-19 pandemic casts new light on plasma therapies

The use of COVID-19 convalescent plasma (CCP) as a therapeutic option, despite its ups and downs, has shown the European Union's renewed interest in plasma-derived medicinal products (PDMPs).
 InfographicPromoted content
Health 17-03-2021

Europe needs to collect more plasma

Download PDF  

Plasma-derived medicinal products (PDMPs), derived from human plasma from healthy donors, are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin....